Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
Cellerant Therapeutics
INSYS Therapeutics Inc
Millennium Pharmaceuticals, Inc.